This site is intended for healthcare professionals only
LoginRegister
Biocon Receives 5 USFDA Observations at Bengaluru Biosimilars SiteBiocon Biologics Eyes USD 75 Billion Oncology Market, Adds 3 New Biosimilar Drugs
Export Council PHARMEXCIL Holds Strategic Talks with Govt on Scaling USD 30.47 Billion Pharma ExportsExport Council PHARMEXCIL Holds Strategic Talks with Govt on Scaling USD 30.47 Billion Pharma...
Warburg Pincus in Talks to Acquire Maneesh Pharmas Doxinate Portfolio in Rs 1,800 Cr Deal: ReportEli Lilly, Nimbus Tie Up in USD 1.35 Billion AI-Driven Pact to Develop Oral Obesity Drugs
Novo Nordisk Projects Oral Weight-Loss Pills to Take One-Third of GLP-1 Market by 2030Novo Nordisk's US Public Affairs Head Jennifer Duck Exits Amid Pricing Pressure, Obesity Drug Battle
Eli Lilly to Acquire Ajax Therapeutics in USD 2.3 Billion Cancer Drug PushEli Lilly in Talks to Acquire Ventyx Biosciences in USD 1 Billion-Plus Deal
Contract Pharmacists Protest at SMS Medical College, Demand Reinstatement, Recruitment ProbeNo More Court Trials for Pharma Firms in Minor Drug Law Violations
Biocon Employee Passes Away in Suspected Workplace SuicideBiocon Employee Passes Away in Suspected Workplace Suicide
Abhayrab Safe via Authorised Channels, Clarifies Indian Immunologicals Amid Fake Vaccine AlertsAbhayrab Safe via Authorised Channels, Clarifies Indian Immunologicals Amid Fake Vaccine Alerts
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsBiocon Strengthens Control Over Biologics Unit, Issues Shares to Mylan, Other Investors
Haryana Flags Over 30 Drug Overcharging Cases, Seeks NPPA ActionHaryana Flags Over 30 Drug Overcharging Cases, Seeks NPPA Action
DccHealth Ministry Mulls Extension for Pharma Firms to Comply with Revised Schedule M GMP Norms
Torrent Pharma Plans Rs 12,500 Cr Fund Raise Through Secured NCD IssueTorrent Pharma Plans Rs 12,500 Cr Fund Raise Through Secured NCD Issue
X